Writing A Bedside Specimen Identification Protocol For TB Laboratories
A tuberculosis specimen can lose its diagnostic value before it reaches the laboratory if it is collected from the wrong person, placed in the wrong container, or labelled after the event. A clear bedside protocol reduces these risks by making identification, labelling, verification and escalation consistent across wards, clinics, outreach services and community collection points.
For Australian services, the protocol should work in a busy metropolitan hospital in Sydney or Melbourne as well as a remote health centre in the Northern Territory or Western Australia. It must account for different staffing models, intermittent connectivity, Aboriginal and Torres Strait Islander community settings, and specimens collected during respiratory assessment rather than at a conventional pathology desk.
The document should sit within the laboratory quality management system and align with local requirements, including the Privacy Act 1988, state or territory work health and safety duties, infection prevention procedures, and NATA expectations where accreditation applies. It should be practical enough for routine use, auditable during an incident, and simple enough to follow when a patient is distressed or the service is under pressure.
Define The Safety And Quality Purpose
Begin by stating what the protocol controls. Its purpose is to ensure that every TB specimen is linked to the correct patient, collection episode, specimen type and request. It should cover sputum, induced sputum, gastric aspirate, bronchoalveolar lavage, tissue, body fluids and other samples submitted for microscopy, nucleic acid testing, culture or drug susceptibility testing.
The scope should include anyone who may identify or label a specimen: nurses, doctors, Aboriginal health practitioners, pathology collectors, respiratory technicians and trained outreach staff. State whether the procedure applies in emergency departments, inpatient wards, outpatient respiratory clinics, correctional health services, aged-care facilities and mobile clinics. A short scope prevents staff from assuming that the process applies only inside the laboratory.
A quality manual provides the wider framework for document control, responsibilities and records. The GLI resource on laboratory quality manual development can help place this bedside procedure within a complete TB diagnostic quality system rather than treating it as an isolated form.
Set Roles, Timing, And Required Information
The protocol should identify who confirms the patient’s identity, who labels the container, who checks the details and who handles a discrepancy. In most settings, the person collecting the specimen should label it immediately at the bedside and complete the request details before moving to the next patient. A second check is valuable for high-risk situations, such as an unconscious patient, a child, a patient with limited English, or a specimen collected by an unfamiliar team.
Specify the approved identifiers. In Australia, these will commonly include the patient’s full name, date of birth and medical record number, although the local pathology service may require a Medicare number, hospital unit record number or another approved identifier. The protocol should state the minimum number of matching identifiers and make clear that a bed number, room number or diagnosis is not an acceptable substitute.
Record the collection date and time, specimen type, anatomical source, collector’s identity and requesting clinician. If multiple sputum specimens are required, each container needs an unambiguous sequence, such as “spot”, “early morning” or “specimen 2”, according to the diagnostic pathway. Avoid vague terms such as “sample” or “respiratory material”, which make later interpretation difficult.
Build The Bedside Identification Process
Write the procedure as a sequence of observable actions. First, ask the patient to state their full name and date of birth where possible. Compare those details with the approved wristband, electronic record and request form. Do not prompt the patient with the answer. For a patient unable to respond, use the authorised alternative identification process and document the source of verification.
Next, explain the collection and check that the container is the correct, leak-resistant, laboratory-approved vessel. For sputum, distinguish a deep respiratory specimen from saliva and tell the patient where and how to collect it. Outdoor or well-ventilated collection areas may be used according to local infection control arrangements, particularly when a person has a suspected airborne infection. Staff should avoid opening the container unnecessarily.
Label the container while it remains in the patient’s presence. The label should be legible, firmly attached and positioned so that it does not cover the lid, specimen level or manufacturer information needed for safe processing. If a barcode is used, scan it against the patient record and confirm that the displayed identity matches the request. A barcode is a checking tool, not permission to skip visual verification.
Require a final “three-way match” between the patient, container and request or electronic order. The collector should compare identifiers aloud or silently according to privacy requirements, then sign or electronically authenticate the collection. The protocol should prohibit pre-labelling empty containers, labelling from memory, leaving an unlabelled specimen unattended and applying labels at a central desk after a round of collections.
Control Labels, Forms, And Digital Records
Include a model label or annotated example in the procedure. Show where the patient identifiers, collection time, specimen category and collector details appear. Define acceptable writing materials and label formats, including how to deal with condensation, small containers and labels that may detach during refrigerated transport. If the service uses a LIMS, explain what is entered at the bedside and what is verified when the specimen is received.
Australian laboratories may use different systems across public hospitals, private pathology providers and Aboriginal Community Controlled Health Services. A protocol should therefore describe the required data rather than depend entirely on a particular software screen. It should also specify downtime steps for electronic medical record outages, including use of approved paper forms, temporary identifiers and later reconciliation.
Privacy deserves specific attention. Place request forms and labels so other patients cannot see unnecessary information, particularly in shared waiting areas or mobile clinics. Use secure transport bags and approved electronic messaging. Do not send patient identifiers through personal phones or informal messaging platforms. Retain records according to the organisation’s document retention schedule and applicable health-record obligations.
The document itself needs version control. Include an owner, approval authority, effective date, review date and change history. Train new staff before they collect TB specimens independently, and retain competency evidence. Posters may support the process, but they should point to the controlled procedure rather than become an unofficial alternative.
Manage Exceptions, Transport, And Privacy
A specimen with missing, mismatched or unreadable identification must trigger a defined response. Staff should not quietly correct a label or rely on recognition of the patient. The collector or supervising clinician should be contacted, the discrepancy documented and the laboratory consulted before testing proceeds. For critical specimens that cannot be recollected, the laboratory director or authorised senior scientist should assess the risk and record the decision.
Describe rejection and conditional acceptance rules in plain language. A leaking container, wrong specimen type, absent collection time or major identifier mismatch may require rejection, recollection or referral for clinical authorisation. The protocol should distinguish a correctable administrative error from a patient-identification failure. This supports consistent decisions across Melbourne hospitals, rural Queensland clinics and remote services.
Transport instructions should cover packaging, temperature, maximum holding time, courier arrangements and after-hours handover. TB specimens may travel from a community clinic to a regional hub before reaching the testing laboratory, so the chain of custody must remain visible. Include instructions for separating specimens from paperwork where required, managing spills and disposing of contaminated materials. Guidance on waste segregation procedures can help align the protocol with broader biosafety controls before decontamination.
The procedure should also define communication with the receiving laboratory. Record who was contacted, when, the advice provided and any limitation on interpretation. This is especially important when weather, long distances or limited courier schedules delay transport from remote Western Australian or Northern Territory locations.
Test, Review, And Maintain The Protocol
A protocol is reliable only when staff can use it under realistic conditions. Test it with ordinary and difficult scenarios: a patient with the same surname as another patient, a non-verbal patient, two specimens collected in one visit, a failed barcode scan and an electronic record outage. Observe whether staff perform each step without relying on memory or informal workarounds.
Monitor a small set of indicators. Useful measures include the percentage of specimens with complete identifiers, rejected TB specimens, unlabeled or mislabelled containers, discrepancies found at accessioning, and the time between collection and laboratory receipt. Review incidents by looking for system causes such as confusing labels, insufficient lighting, poor printer placement, workload or unclear responsibility.
Use audit findings to update training and workflow. A recurring mismatch may indicate that the request form, electronic order and container label display different identifiers. A high rate of saliva specimens may point to inadequate patient instructions rather than poor laboratory testing. Changes should be approved through the quality system, communicated to all collection areas and checked after implementation.
The following comparison can help teams choose controls that fit their setting:
| Protocol element | Minimum control | Stronger operational control |
|---|---|---|
| Patient identification | Two approved identifiers checked against the request | Patient states identifiers and staff scan and visually confirm the record |
| Specimen labelling | Label applied immediately at the bedside | Barcode printed at point of care and matched electronically |
| Multiple specimens | Clear sequence and collection time | Predefined episode identifiers with automated prompts |
| Downtime | Approved paper form and later data entry | Downtime pack, reconciliation log and supervisor review |
| Discrepancies | Stop, document and escalate | Formal risk assessment, incident review and corrective action |
| Staff competence | Induction and procedure access | Observed assessment, refresher training and periodic audit |
Practical Controls For Australian Services
- Use Australian spelling and local terminology consistently across labels, forms and training materials.
- Include state or territory escalation contacts for specimen rejection, exposure incidents and after-hours advice.
- Provide a low-literacy patient explanation for sputum collection and arrange interpreter support when required.
- Check that labels and barcode printers suit the local market, including rural procurement and replacement lead times.
- Protect identifiers in shared waiting areas, mobile vans and Aboriginal Community Controlled Health Service settings.
- Review the procedure against NATA accreditation requirements, organisational policy and current WHS arrangements.
A well-designed bedside identification protocol turns a simple label into a series of deliberate safety checks. Make the controlled procedure available through the GLI Quality Tool resources, train every staff group that collects specimens, and use audit results to keep the process dependable from the first patient interaction to final laboratory accessioning.